RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Eckert & Ziegler Strahlen und Medizintechnik ROA 2024

Eckert & Ziegler Strahlen und Medizintechnik ROA

0.06

Eckert & Ziegler Strahlen und Medizintechnik Dividend yield

1.36 %

Ticker

EUZ.DE

ISIN

DE0005659700

WKN

565970

In 2024, Eckert & Ziegler Strahlen und Medizintechnik's return on assets (ROA) was 0.06, a -16.7% increase from the 0.07 ROA in the previous year.

Eckert & Ziegler Strahlen und Medizintechnik Aktienanalyse

What does Eckert & Ziegler Strahlen und Medizintechnik do?

The Eckert & Ziegler Strahlen und Medizintechnik AG is an international company that offers both medical and industrial products and services in the field of radiation application. The company was founded in 1997 and has its headquarters in Berlin. The history of the company began in the 1960s when the two founders, Dr. Andreas Eckert and Dr. Edgar Ziegler, started producing medical isotopes for the diagnosis and therapy of cancer patients. After initially working in a laboratory in Berlin, they founded Eckert & Ziegler Isotope Products GmbH in 1983. In the following years, the company expanded and added radiation sources for industrial applications to its portfolio. In 1997, Eckert & Ziegler Strahlen und Medizintechnik AG was founded to consolidate the two business areas and expand the international business. Today, the company operates worldwide and employs over 800 people. The company's business model focuses on the application of radiation in various industries. The company relies on different business areas that can be divided into medical and industrial applications. In the medical field, Eckert & Ziegler develops and produces radiation sources for the diagnosis and therapy of cancer and other diseases. The products include radioactive isotopes used for the production of medications, the equipment of clinics, and research. Particularly important are radioactive substances for the treatment of prostate cancer, which are highly sought after due to their high effectiveness in patients. In the field of industrial applications, the company offers radiation sources for various industries, such as medical imaging, sterilization of medical devices, or non-destructive testing of materials in the automotive and aviation industries. The company also develops customized solutions for specific customer needs. Another important business area is the disposal of radioactive waste. Here, the company offers solutions for hospitals, research institutions, and companies that work with radioactive substances and must comply with legal requirements for disposal. Eckert & Ziegler is a company that focuses on innovation and research. The company continuously invests in research and development to keep its products and services up to date. For this purpose, the company maintains close relationships with research institutions and universities to develop new technologies and products. The company also strives to make its products and services environmentally friendly and sustainable. It relies on the use of renewable energies, energy efficiency, and recyclability of products. Overall, Eckert & Ziegler Strahlen und Medizintechnik AG is a leading company in the application of radiation in medical and industrial applications. The company relies on innovative products and solutions to meet the needs of its customers. Eckert & Ziegler Strahlen und Medizintechnik ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Eckert & Ziegler Strahlen und Medizintechnik's Return on Assets (ROA)

Eckert & Ziegler Strahlen und Medizintechnik's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Eckert & Ziegler Strahlen und Medizintechnik's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Eckert & Ziegler Strahlen und Medizintechnik's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Eckert & Ziegler Strahlen und Medizintechnik’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Eckert & Ziegler Strahlen und Medizintechnik Stock

What is the Return on Assets (ROA) of Eckert & Ziegler Strahlen und Medizintechnik this year?

The Return on Assets (ROA) of Eckert & Ziegler Strahlen und Medizintechnik is 0.06 undefined this year.

What was the ROA of Eckert & Ziegler Strahlen und Medizintechnik compared to the previous year?

The ROA of Eckert & Ziegler Strahlen und Medizintechnik has increased by -16.7% compared to the previous year.

What consequences do high ROA have for investors of Eckert & Ziegler Strahlen und Medizintechnik?

A high ROA is advantageous for investors of Eckert & Ziegler Strahlen und Medizintechnik, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Eckert & Ziegler Strahlen und Medizintechnik?

A low ROA can be unfavorable for investors of Eckert & Ziegler Strahlen und Medizintechnik as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Eckert & Ziegler Strahlen und Medizintechnik affect the company?

An increase in ROA of Eckert & Ziegler Strahlen und Medizintechnik can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Eckert & Ziegler Strahlen und Medizintechnik impact the company?

A reduction in the ROA of Eckert & Ziegler Strahlen und Medizintechnik can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Eckert & Ziegler Strahlen und Medizintechnik?

Some factors that can influence the ROA of Eckert & Ziegler Strahlen und Medizintechnik include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Eckert & Ziegler Strahlen und Medizintechnik important for investors?

The ROA of Eckert & Ziegler Strahlen und Medizintechnik is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Eckert & Ziegler Strahlen und Medizintechnik take to improve ROA?

To improve ROA, Eckert & Ziegler Strahlen und Medizintechnik can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Eckert & Ziegler Strahlen und Medizintechnik pay?

Over the past 12 months, Eckert & Ziegler Strahlen und Medizintechnik paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 1.36 %. For the coming 12 months, Eckert & Ziegler Strahlen und Medizintechnik is expected to pay a dividend of 0.55 EUR.

What is the dividend yield of Eckert & Ziegler Strahlen und Medizintechnik?

The current dividend yield of Eckert & Ziegler Strahlen und Medizintechnik is 1.36 %.

When does Eckert & Ziegler Strahlen und Medizintechnik pay dividends?

Eckert & Ziegler Strahlen und Medizintechnik pays a quarterly dividend. This is distributed in the months of July, July, July, June.

How secure is the dividend of Eckert & Ziegler Strahlen und Medizintechnik?

Eckert & Ziegler Strahlen und Medizintechnik paid dividends every year for the past 23 years.

What is the dividend of Eckert & Ziegler Strahlen und Medizintechnik?

For the upcoming 12 months, dividends amounting to 0.55 EUR are expected. This corresponds to a dividend yield of 1.49 %.

In which sector is Eckert & Ziegler Strahlen und Medizintechnik located?

Eckert & Ziegler Strahlen und Medizintechnik is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eckert & Ziegler Strahlen und Medizintechnik kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eckert & Ziegler Strahlen und Medizintechnik from 5/31/2024 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 5/29/2024.

When did Eckert & Ziegler Strahlen und Medizintechnik pay the last dividend?

The last dividend was paid out on 5/31/2024.

What was the dividend of Eckert & Ziegler Strahlen und Medizintechnik in the year 2023?

In the year 2023, Eckert & Ziegler Strahlen und Medizintechnik distributed 0.5 EUR as dividends.

In which currency does Eckert & Ziegler Strahlen und Medizintechnik pay out the dividend?

The dividends of Eckert & Ziegler Strahlen und Medizintechnik are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eckert & Ziegler Strahlen und Medizintechnik stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Eckert & Ziegler Strahlen und Medizintechnik

Our stock analysis for Eckert & Ziegler Strahlen und Medizintechnik Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eckert & Ziegler Strahlen und Medizintechnik Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.